Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrobulbar dexmedetomidine in pediatric vitreoretinal surgery
ChiCTR1800019634Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine, ropivacaine and fentanyl in retinal detachment (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Consumption of fentanyl. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacainefentanyl
03
Conditions
retinal detachment
Beyond the preview
Go deeper on ChiCTR1800019634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019634.